Primate Monocytes - CD14, CD16 - Ziegler-Heitbrock

Contact

Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery disease.

Abstract

Data presented in this article are supplementary material to our research article entitled "Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients" [1]. This article contains the data of study population, diagnostic ability of CD14++CD16+ monocytes to identify thin-cap fibroatheromas, and association between laboratory variables and plaque properties.

Authors: Yamamoto H, Yoshida N, Shinke T, Otake H, Kuroda M, Sakaguchi K, Hirota Y, Toba T, Takahashi H, Terashita D, Uzu K, Tahara N, Shinkura Y, Kuroda K, Nagasawa Y, Nagano Y, Tsukiyama Y, Yanaka KI, Emoto T, Sasaki N, Yamashita T, Ogawa W, Hirata KI.
Journal: Data Brief. 2018 Mar 10;18:172-175.
Year: 2018
PubMed: Find in PubMed